GBM is also affected by WWOX, a cytoskeleton-related protein that interacts with ezrin, dystroglycan, or GSK−3β; it also influences on expression of DCLK, NEFL, NEFM, and MAP2/4/6 genes. The gene discussed is MAP2; the disease is glioblastoma.